Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liver resection patients | All patients that underwent elective liver resection for both malignant and benign diseases. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Liver resection | Procedure | Hepatectomy including both minor and major. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Pulmonary embolism | Blood clots in the lungs that may lead to sudden death. | up to January 2012 |
| Measure | Description | Time Frame |
|---|---|---|
| Complications | Any type of post-operative complications graded according to the Clavien-Dindo Classification of Surgical Complications | up to January 2012 |
| Length of hospital stay | The duration of hospitalization in days. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All consecutive patients that will undergo liver resection for any type of liver disease.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jacques Belghiti, MD | Beaujon Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Prof. Jacques Belghiti | Paris | Clichy | 92110 | France |
| Type | Date | Date Unknown |
|---|---|---|
| Release | Jan 12, 2016 | |
| Reset | Feb 8, 2016 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Jan 12, 2016 | Feb 8, 2016 |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D011655 | Pulmonary Embolism |
| D019851 | Thrombophilia |
| D003643 | Death |
| ID | Term |
|---|---|
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |
Not provided
Not provided
| ID | Term |
|---|---|
| D006498 | Hepatectomy |
| C074011 | 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid |
| ID | Term |
|---|---|
| D013505 | Digestive System Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
| Computed Tomography | Radiation | Computed Tomography +/- pulmonary angiography |
|
|
| up to January 2012 |
| Mortality | Post-operative 90-Day Mortality | up to January 2012 |
| D016769 |
| Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |